Elevance Health (0HG8) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Elevance Health (0HG8) has a cash flow conversion efficiency ratio of 0.002x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($84.00 Million) by net assets ($44.03 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Elevance Health - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Elevance Health's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Elevance Health Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Elevance Health ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Moody's Corp.
LSE:0K36
|
0.181x |
|
The Sherwin-Williams Company
SA:S1HW34
|
0.513x |
|
Sherwin-Williams Co
NYSE:SHW
|
0.284x |
|
Marriott International Inc
NASDAQ:MAR
|
-0.220x |
|
AMERICA MOVIL SAB DE CV
MX:AMXB
|
0.166x |
|
Banco Bilbao Vizcaya Argentaria S.A
PINK:BBVXF
|
0.065x |
|
KKR & Co LP
NYSE:KKR
|
0.032x |
|
BYD Co Ltd Class A
SHE:002594
|
0.076x |
Annual Cash Flow Conversion Efficiency for Elevance Health (2001–2025)
The table below shows the annual cash flow conversion efficiency of Elevance Health from 2001 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $44.03 Billion | $4.29 Billion | 0.097x | -30.50% |
| 2024-12-31 | $41.43 Billion | $5.81 Billion | 0.140x | -31.46% |
| 2023-12-31 | $39.41 Billion | $8.06 Billion | 0.205x | -11.51% |
| 2022-12-31 | $36.33 Billion | $8.40 Billion | 0.231x | -0.14% |
| 2021-12-31 | $36.13 Billion | $8.36 Billion | 0.232x | -28.09% |
| 2020-12-31 | $33.20 Billion | $10.69 Billion | 0.322x | +68.53% |
| 2019-12-31 | $31.73 Billion | $6.06 Billion | 0.191x | +42.47% |
| 2018-12-31 | $28.54 Billion | $3.83 Billion | 0.134x | -15.08% |
| 2017-12-31 | $26.50 Billion | $4.18 Billion | 0.158x | +23.68% |
| 2016-12-31 | $25.10 Billion | $3.20 Billion | 0.128x | -28.52% |
| 2015-12-31 | $23.04 Billion | $4.12 Billion | 0.179x | +28.56% |
| 2014-12-31 | $24.25 Billion | $3.37 Billion | 0.139x | +12.72% |
| 2013-12-31 | $24.77 Billion | $3.05 Billion | 0.123x | +6.89% |
| 2012-12-31 | $23.80 Billion | $2.74 Billion | 0.115x | -20.42% |
| 2011-12-31 | $23.29 Billion | $3.37 Billion | 0.145x | +143.55% |
| 2010-12-31 | $23.81 Billion | $1.42 Billion | 0.059x | -51.32% |
| 2009-12-31 | $24.86 Billion | $3.04 Billion | 0.122x | +3.32% |
| 2008-12-31 | $21.43 Billion | $2.54 Billion | 0.118x | -37.40% |
| 2007-12-31 | $22.99 Billion | $4.34 Billion | 0.189x | +14.84% |
| 2006-12-31 | $24.58 Billion | $4.04 Billion | 0.165x | +26.29% |
| 2005-12-31 | $24.99 Billion | $3.26 Billion | 0.130x | +94.57% |
| 2004-12-31 | $19.46 Billion | $1.30 Billion | 0.067x | -64.86% |
| 2003-12-31 | $6.00 Billion | $1.14 Billion | 0.191x | +3.11% |
| 2002-12-31 | $5.36 Billion | $991.10 Million | 0.185x | -41.84% |
| 2001-12-31 | $2.06 Billion | $654.60 Million | 0.318x | -- |
About Elevance Health
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad… Read more